Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?

Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?

Submitted by admin on May 23, 2022 - 6:44pm
Source: 
Motley Fool
News Tags: 
Amgen
biosimilars
Stelara
JNJ
Headline: 
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
snippet: 
  • Amgen's biosimilar drug candidate was comparable to Stelara in efficacy and safety.
  • The biosimilar drug's annual sales could reach $1 billion for Amgen.
  • Amgen looks like a good stock to buy for steady and growing income.

Do Not Allow Advertisers to Use My Personal information